View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this podcast, Dr Dominique Laurent Braun discusses his micro-elimination program, the Swiss HCVree trial, designed to prevent hepatitis C virus (HCV) transmission among HIV-positive men who have sex with men. The study employed a test-and-treat approach to eliminate HCV infection in this key target population and could be a model for other countries to eliminate HCV infection in certain populations.
This program has been made available online.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Expert selections of important viral hepatitis data from AASLD 2022, including studies of patients with HBV, HDV, and HCV, from Clinical Care Options (CCO)
Nancy Reau, MD
Stefan Zeuzem, MD
Released: November 16, 2022
Expert summaries of key data in older patients with HBV, from Clinical Care Options (CCO)
Graham R. Foster, FRCP, PhD
Nancy Reau, MD
Released: November 16, 2022
Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in China, from Clinical Care Options (CCO)
Dee Lee
Jie Li, MD, PhD
Released: October 4, 2022
Dr Nancy Reau on exciting viral hepatitis data from EASL 2022, including HBV, HDV (hepatitis delta), and HCV, from Clinical Care Options (CCO)
Nancy Reau, MD
Released: July 13, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.